Dr. Bhatt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
988102 Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-559-5600Fax+1 402-559-6615
Education & Training
- University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015
- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2009 - 2012
- Tribhuvan University Inst of MedicineClass of 2009
Certifications & Licensure
- IA State Medical License 2021 - 2026
- NE State Medical License 2014 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia Start of enrollment: 2017 Jul 07
- Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids Start of enrollment: 2018 Sep 05
- ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant Start of enrollment: 2019 Jul 30
- Join now to see all
Publications & Presentations
PubMed
- Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704.Mohamed L Sorror, Wael Saber, Brent R Logan, Nancy L Geller, Anna Bellach
Blood Advances. 2025-03-18 - Chemotherapy Trends in Acute Myeloid Leukemia: 2004 to 2020.Aditya Ravindra, Bradley Loeffler, Luna Acharya, Avantika Pyakuryal, Vijaya Raj Bhatt
Clinical Lymphoma, Myeloma & Leukemia. 2025-03-01 - A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies.Matthew S Davids, Danielle M Brander, Yesid Alvarado-Valero, Catherine S Diefenbach, Daniel N Egan
Blood Advances. 2025-02-25
Abstracts/Posters
- Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)Vijaya R. Bhatt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A...Vijaya R. Bhatt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Therapy preference scale: A novel questionnaire to understand patients’ preferences of cancer treatment.2019 ASCO Annual Meeting - 6/1/2019
- Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Distinguished Scientist: Vijaya Bhatt, MBBSFebruary 5th, 2021
- ‘Health Care Works Are Exhausted,’ UNMC Letter Receives 2k+ SignaturesNovember 18th, 2020
- UNMC and NE Medicine Trial Will Test if Cancer Drugs Can Remove LeukemiaNovember 16th, 2020
- Join now to see all
Grant Support
- Aging trajectories and outcomes of older adults with acute myeloid leukemiaUNIVERSITY OF NEBRASKA MEDICAL CENTER2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: